CVA Family Office LLC Buys 325 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CVA Family Office LLC boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 29.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,440 shares of the pharmacy operator’s stock after purchasing an additional 325 shares during the quarter. CVA Family Office LLC’s holdings in Walgreens Boots Alliance were worth $55,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Rise Advisors LLC acquired a new stake in Walgreens Boots Alliance in the fourth quarter worth about $27,000. Iron Horse Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance by 56.0% in the first quarter. Iron Horse Wealth Management LLC now owns 635 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 228 shares during the last quarter. GoalVest Advisory LLC raised its stake in shares of Walgreens Boots Alliance by 10,828.6% in the second quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 758 shares during the last quarter. City State Bank purchased a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $30,000. Finally, Tompkins Financial Corp raised its stake in shares of Walgreens Boots Alliance by 215.7% in the first quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator’s stock worth $42,000 after purchasing an additional 647 shares during the last quarter. Institutional investors own 57.33% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA opened at $34.15 on Tuesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.78 and a quick ratio of 0.43. The business’s 50 day moving average price is $37.73 and its 200-day moving average price is $41.61. The firm has a market capitalization of $29.51 billion, a PE ratio of 5.51, a P/E/G ratio of 1.48 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 1 year low of $33.70 and a 1 year high of $55.00.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last released its quarterly earnings data on Thursday, June 30th. The pharmacy operator reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.01. Walgreens Boots Alliance had a return on equity of 16.20% and a net margin of 4.00%. The company had revenue of $32.60 billion for the quarter, compared to analyst estimates of $32.23 billion. During the same quarter in the previous year, the company posted $1.51 earnings per share. The firm’s revenue for the quarter was down 4.2% compared to the same quarter last year. As a group, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 5.02 earnings per share for the current fiscal year.

Walgreens Boots Alliance Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 9th. Investors of record on Friday, August 19th were issued a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 5.62%. The ex-dividend date of this dividend was Thursday, August 18th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.48. Walgreens Boots Alliance’s payout ratio is currently 30.97%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Barclays reduced their price objective on Walgreens Boots Alliance from $50.00 to $45.00 and set an “equal weight” rating for the company in a research note on Friday, June 24th. JPMorgan Chase & Co. reduced their price target on Walgreens Boots Alliance from $52.00 to $45.00 and set a “neutral” rating for the company in a research report on Friday, July 8th. Royal Bank of Canada reduced their price target on Walgreens Boots Alliance from $46.00 to $42.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 5th. Truist Financial reduced their price target on Walgreens Boots Alliance from $50.00 to $42.00 and set a “hold” rating for the company in a research report on Friday, July 1st. Finally, Cowen reduced their price target on Walgreens Boots Alliance to $49.00 in a research report on Thursday, June 9th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $46.25.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

See Also

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.